Conclusion Although data are limited , there is a strong significant relationship between plantar flexor muscle strength and treadmill walking ability .
Background and Objective Exercise is a widely accepted treatment known to improve walking ability in persons with peripheral arterial disease ( PAD ) ; however , it has not been confirmed as to whether exercise improves fitness and performance-based function and , consequently , performance of activities of daily living ( ADL ) .
This systematic review aims to identify whether any mode of structured exercise improves physical fitness or performance-based tests of function and whether improvement in walking ability is related to an improvement in these outcomes .
Data Sources and Study Selection Eligible studies included r and omized controlled trials ( RCTs ) using an exercise intervention for the treatment of intermittent claudication with fitness ( including the 6-min walk ( 6MW ) , aerobic capacity , shuttle and muscle strength ) tests and performance-based tests of function as the outcomes .
Benefit of exercise conditioning for patients with peripheral arterial disease.
Patients with atherosclerotic peripheral arterial disease ( PAD ) of the lower extremities have impaired walking ability due to exercise-induced muscle ischemia and the result ant pain of intermittent claudication . To evaluate the benefit of exercise training as a treatment for patients with PAD , as well as possible mechanisms associated with improvement , we r and omly assigned 19 men with disabling claudication to treated and control groups . Treatment consisted of supervised treadmill walking ( 1 hr/day , 3 days/wk , for 12 weeks ) with progressive increases in speed and grade as tolerated . Grade d treadmill testing was performed to maximal toleration of claudication pain on entry and after 12 weeks of training to define changes in peak exercise performance . After 12 weeks , treated subjects had increased their peak walking time 123 % , peak oxygen consumption 30 % , and pain-free walking time 165 % ( all p less than 0.05 ) . Control subjects had no change in peak oxygen consumption , but after 12 weeks , peak walking time increased 20 % ( p less than 0.05 ) . In treated subjects , maximal calf blood flow ( measured by a plethysmograph ) increased 38 + /- 45 % ( p less than 0.05 ) , but the change in flow was not correlated to the increase in peak walking time . Elevated plasma concentrations of acylcarnitines have been associated with the functional impairment of PAD and may reflect the metabolic state of ischemic skeletal muscle . In treated subjects , a 26 % decrease in resting plasma short-chain acylcarnitine concentration was correlated with improvement in peak walking time ( r = -0.78 , p less than 0.05 ) . ( ABSTRACT TRUNCATED AT 250 WORDS
Conclusion Although data are limited , there is a strong significant relationship between plantar flexor muscle strength and treadmill walking ability .
Background and Objective Exercise is a widely accepted treatment known to improve walking ability in persons with peripheral arterial disease ( PAD ) ; however , it has not been confirmed as to whether exercise improves fitness and performance-based function and , consequently , performance of activities of daily living ( ADL ) .
This systematic review aims to identify whether any mode of structured exercise improves physical fitness or performance-based tests of function and whether improvement in walking ability is related to an improvement in these outcomes .
Data Sources and Study Selection Eligible studies included r and omized controlled trials ( RCTs ) using an exercise intervention for the treatment of intermittent claudication with fitness ( including the 6-min walk ( 6MW ) , aerobic capacity , shuttle and muscle strength ) tests and performance-based tests of function as the outcomes .